{"id":"W4317952699","doi":"10.1093/bjd/ljac140.009","title":"309 Tralokinumab demonstrated a consistent safety profile with up to 42 months of treatment in moderate-to-severe atopic dermatitis: including adverse events of special interest","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"SKiN Health; Queen's University; Probity Medical Research; Dalhousie University","funders":"","keywords":"Medicine; Adverse effect; Atopic dermatitis; Placebo; Dosing; Interim analysis; Internal medicine; Clinical trial; Pediatrics; Dermatology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005248757,0.0002511698,0.0005922574,0.0001216538,0.0001799056,0.0003473799,0.0001829345,0.0003788919,0.006382267],"category_scores_gemma":[0.0006271268,0.0001026363,0.0005471493,0.0001427187,0.0001205505,0.0002286627,0.00009962727,0.0008373205,0.002190153],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002943357,"about_ca_system_score_gemma":0.0004129839,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006502154,"about_ca_topic_score_gemma":0.001953533,"domain_scores_codex":[0.9997036,0.00008050389,0.00003258936,0.00005305214,0.00009255361,0.00003770213],"domain_scores_gemma":[0.9996051,0.0001068791,0.00007474303,0.00004922751,0.0001129792,0.00005108658],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.03167239,0.005888466,0.01442858,0.001866464,0.000481342,0.0007048583,0.0002033914,0.001774295,0.4869612,0.0003751823,0.014994,0.4406497],"study_design_scores_gemma":[0.01479971,0.1814504,0.3406187,0.0004041624,0.001293368,0.009615377,0.0002127519,0.008763595,0.3130777,0.0006532378,0.1289565,0.0001544266],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9690133,0.00766019,0.003436202,0.00048248,0.0001833771,0.0007117915,0.003418367,0.0004850681,0.01460928],"genre_scores_gemma":[0.9891668,0.0009363688,0.001309232,0.0002858798,0.00004306628,0.0001576541,0.001505134,0.00002953079,0.006566361],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006382267,"threshold_uncertainty_score":0.0213508,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02745081945969147,"score_gpt":0.2847009345863062,"score_spread":0.2572501151266148,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}